Archimed acquires PET radiopharmaceuticals company IRAB
Tuesday, June 9, 2026 · first reported by PE Hub
Archimed acquires IRAB, a Barcelona-based PET radiopharmaceuticals developer founded in 2016.
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 source- Antin agrees sale of majority stake in Vicinity Energy to Harrison StreetPrivate Equity Wire +3
- CPP Investments sells A$4.5bn Australian toll road stakes to TransurbanIPE Real Assets
- Sycamore nears $9bn sale of Boots to Weston familyPrivate Equity Wire
- Eagle Point backs $450m US government-leased real estate recapitalisationIPE Real Assets
- CSC acquires 50% Watergardens mall stake from QIC for A$480mIPE Real Assets
- Lone Star buys €216m Dutch residential portfolio from Catella fundIPE Real Assets